Experimental animal models for moyamoya disease and treatment: a pathogenesis-oriented scoping review

Neurosurgical Focus
|September 1, 2021
PubMed
Abstract

Insights

This review of Moyamoya disease animal models found surgical, genetic, and immunological approaches are used. No single model fully replicates the disease, highlighting the need for multietiology models.

Area of Science:

  • Neurology
  • Vascular Biology
  • Genetics

Background:

  • Moyamoya disease (MMD) is a progressive intracranial steno-occlusive disease affecting major cerebral arteries.
  • The exact cause of MMD is unknown, but genetic factors like RNF213 are implicated.
  • A significant hurdle in MMD research is the lack of animal models that accurately mimic human disease pathogenesis.

Purpose of the Study:

  • To conduct a scoping review of existing experimental animal models for Moyamoya disease.
  • To analyze the characteristics and methodologies of current MMD animal models.
  • To identify strategies for developing improved future MMD models.

Main Methods:

  • Systematic literature search of PubMed, Web of Science, and Scopus databases.
  • Inclusion and exclusion criteria were applied by two independent reviewers.
  • Citation searching was used to identify additional relevant articles.

Main Results:

  • 44 articles were included in the review.
  • Animal models were generated using surgical (56.8%), immunological (15.9%), genetic (13.6%), or combined (13.6%) approaches.
  • Surgical models induced chronic cerebral hypoperfusion, genetic models used disease-related genes, and immunological models mimicked vasculitis.

Conclusions:

  • Current MMD animal models employ surgical, immunological, or genetic strategies.
  • Each model captures certain aspects of MMD but none fully recapitulate the disease's development and progression.
  • Future research should focus on developing multietiology models to better understand and treat Moyamoya disease.

Related Concept Videos